FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4240871490> ?p ?o ?g. }

• W4240871490 endingPage "225" @default.
• W4240871490 startingPage "225" @default.
• W4240871490 abstract "Early acute graft dysfunction continues to plague successful lung transplantation. Reperfusion injury is characterized by an increase in pulmonary vascular resistance, poor oxygenation, decreased pulmonary compliance, and increased pulmonary capillary permeability leading to pulmonary edema. The literature consistently shows that Melatonin is one of the most potent oxygen free radical scavengers with the ability to neutralize the hydroxyl radical, singlet oxygen, the peroxyl radical and the superoxide anion. It is believed to directly detoxify the free radical by electron donation and to alter enzyme activity, ie, superoxide dismutase, to augment the antioxidative defense. Its antioxidant effect has been shown to protect nuclear DNA, membrane lipids and cystosolic proteins. It is readily absorbed and it crosses all physiologic barriers.The University of Zurich group examined the effects of donor and recipient treatment with Melatonin in the rat single lung transplantation model after 18 hours of cold ischemia and 2 hours of reperfusion. The study demonstrated that the Melatonin treated group showed significantly improved oxygenation and reduced peak airway pressures. There was a decrease in lipid peroxidation, myeloperoxidase activity and thiobarbituric acid reactive substances in the treated group when compared to non-treated controls. The high BAL nitrite levels in non-treated controls were found to be nearly normal in the Melatonin treated group. However, plasma nitrite levels were close to normal in both groups implicating localized production of nitrous oxide in the injured lung. Neutrophil infiltration in the treatment group was also significantly less than control.While the effects demonstrated are most likely related to Melatonin, it is not clear from this study whether ethanol had an impact on attenuating reperfusion injury. The control group received intraperitoneal saline only, despite the fact that the Melatonin solvent was 10% ethanol. Intraperitoneal ethanol injection would have served as a superior control for this experimental design, since ethanol itself may have some free radical scavenging capabilities. This study also does not delineate whether treatment only at the time of reperfusion is adequate, or whether the drug is required to be present in the lung at the time of initial ischemia (harvest). Since the authors administered Melatonin to both the donors prior to retrieval as well as to the recipients prior to reperfusion, it remains unclear whether or not Melatonin acts primarily during the ischemic period or during reperfusion.Nevertheless, this elegant and simple study makes an interesting contribution to the transplant literature. The details of solvent and dosing strategy should be elucidated in subsequent trials. Early acute graft dysfunction continues to plague successful lung transplantation. Reperfusion injury is characterized by an increase in pulmonary vascular resistance, poor oxygenation, decreased pulmonary compliance, and increased pulmonary capillary permeability leading to pulmonary edema. The literature consistently shows that Melatonin is one of the most potent oxygen free radical scavengers with the ability to neutralize the hydroxyl radical, singlet oxygen, the peroxyl radical and the superoxide anion. It is believed to directly detoxify the free radical by electron donation and to alter enzyme activity, ie, superoxide dismutase, to augment the antioxidative defense. Its antioxidant effect has been shown to protect nuclear DNA, membrane lipids and cystosolic proteins. It is readily absorbed and it crosses all physiologic barriers. The University of Zurich group examined the effects of donor and recipient treatment with Melatonin in the rat single lung transplantation model after 18 hours of cold ischemia and 2 hours of reperfusion. The study demonstrated that the Melatonin treated group showed significantly improved oxygenation and reduced peak airway pressures. There was a decrease in lipid peroxidation, myeloperoxidase activity and thiobarbituric acid reactive substances in the treated group when compared to non-treated controls. The high BAL nitrite levels in non-treated controls were found to be nearly normal in the Melatonin treated group. However, plasma nitrite levels were close to normal in both groups implicating localized production of nitrous oxide in the injured lung. Neutrophil infiltration in the treatment group was also significantly less than control. While the effects demonstrated are most likely related to Melatonin, it is not clear from this study whether ethanol had an impact on attenuating reperfusion injury. The control group received intraperitoneal saline only, despite the fact that the Melatonin solvent was 10% ethanol. Intraperitoneal ethanol injection would have served as a superior control for this experimental design, since ethanol itself may have some free radical scavenging capabilities. This study also does not delineate whether treatment only at the time of reperfusion is adequate, or whether the drug is required to be present in the lung at the time of initial ischemia (harvest). Since the authors administered Melatonin to both the donors prior to retrieval as well as to the recipients prior to reperfusion, it remains unclear whether or not Melatonin acts primarily during the ischemic period or during reperfusion. Nevertheless, this elegant and simple study makes an interesting contribution to the transplant literature. The details of solvent and dosing strategy should be elucidated in subsequent trials." @default.
• W4240871490 created "2022-05-12" @default.
• W4240871490 creator A5062036783 @default.
• W4240871490 date "2002-01-01" @default.
• W4240871490 modified "2023-09-25" @default.
• W4240871490 title "Invited commentary" @default.
• W4240871490 doi "https://doi.org/10.1016/s0003-4975(01)03383-5" @default.
• W4240871490 hasPublicationYear "2002" @default.
• W4240871490 type Work @default.
• W4240871490 citedByCount "0" @default.
• W4240871490 crossrefType "journal-article" @default.
• W4240871490 hasAuthorship W4240871490A5062036783 @default.
• W4240871490 hasBestOaLocation W42408714901 @default.
• W4240871490 hasConcept C126322002 @default.
• W4240871490 hasConcept C181199279 @default.
• W4240871490 hasConcept C185592680 @default.
• W4240871490 hasConcept C203014093 @default.
• W4240871490 hasConcept C2775838275 @default.
• W4240871490 hasConcept C2776151105 @default.
• W4240871490 hasConcept C2777504301 @default.
• W4240871490 hasConcept C2777714996 @default.
• W4240871490 hasConcept C2778004101 @default.
• W4240871490 hasConcept C2778182776 @default.
• W4240871490 hasConcept C2780795997 @default.
• W4240871490 hasConcept C2780829032 @default.
• W4240871490 hasConcept C2781448352 @default.
• W4240871490 hasConcept C2911091166 @default.
• W4240871490 hasConcept C33362165 @default.
• W4240871490 hasConcept C519581460 @default.
• W4240871490 hasConcept C55493867 @default.
• W4240871490 hasConcept C71924100 @default.
• W4240871490 hasConcept C98274493 @default.
• W4240871490 hasConceptScore W4240871490C126322002 @default.
• W4240871490 hasConceptScore W4240871490C181199279 @default.
• W4240871490 hasConceptScore W4240871490C185592680 @default.
• W4240871490 hasConceptScore W4240871490C203014093 @default.
• W4240871490 hasConceptScore W4240871490C2775838275 @default.
• W4240871490 hasConceptScore W4240871490C2776151105 @default.
• W4240871490 hasConceptScore W4240871490C2777504301 @default.
• W4240871490 hasConceptScore W4240871490C2777714996 @default.
• W4240871490 hasConceptScore W4240871490C2778004101 @default.
• W4240871490 hasConceptScore W4240871490C2778182776 @default.
• W4240871490 hasConceptScore W4240871490C2780795997 @default.
• W4240871490 hasConceptScore W4240871490C2780829032 @default.
• W4240871490 hasConceptScore W4240871490C2781448352 @default.
• W4240871490 hasConceptScore W4240871490C2911091166 @default.
• W4240871490 hasConceptScore W4240871490C33362165 @default.
• W4240871490 hasConceptScore W4240871490C519581460 @default.
• W4240871490 hasConceptScore W4240871490C55493867 @default.
• W4240871490 hasConceptScore W4240871490C71924100 @default.
• W4240871490 hasConceptScore W4240871490C98274493 @default.
• W4240871490 hasIssue "1" @default.
• W4240871490 hasLocation W42408714901 @default.
• W4240871490 hasOpenAccess W4240871490 @default.
• W4240871490 hasPrimaryLocation W42408714901 @default.
• W4240871490 hasRelatedWork W1987505311 @default.
• W4240871490 hasRelatedWork W1993916920 @default.
• W4240871490 hasRelatedWork W2053322737 @default.
• W4240871490 hasRelatedWork W2087296494 @default.
• W4240871490 hasRelatedWork W2090713597 @default.
• W4240871490 hasRelatedWork W2091240063 @default.
• W4240871490 hasRelatedWork W2134618383 @default.
• W4240871490 hasRelatedWork W2182752148 @default.
• W4240871490 hasRelatedWork W2186050858 @default.
• W4240871490 hasRelatedWork W2994394112 @default.
• W4240871490 hasVolume "73" @default.
• W4240871490 isParatext "false" @default.
• W4240871490 isRetracted "false" @default.
• W4240871490 workType "article" @default.